Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
FEMYthis companyFemasys Inc.	$1.43	-1.23×	3.88×	9.93×	-1.15×	-203.0%	62.0%	-767.0%	-812.3%	-317.4%	-100.1%	-84.4%	0.8×	0.29×	-9.3×	4.53×	0.0%	1	-18.41	1	D+
AIMDAinos, Inc.	$0.64	-0.47×	0.93×	56.41×	-1.9×	-536.9%	-3767.2%	-11268.3%	-11897.0%	-195.3%	-70.7%	-66.4%	1.45×	-1.14×	-19.65×	1.06×	0.0%	2	-8.34	1	D+
APLMApollomics, Inc.	$18.62	-2.47×	-8.48×	3.18×	-2.65×	-2022.9%	97.0%	-111.4%	-128.7%	343.1%	-1586.8%	-38.4%	-0.2×	0.29×	-145.74×	0.96×	0.0%	2	-148.2	2	C+
COCHEnvoy Medical, Inc.	$7.31	-0.54×	-1.31×	63.8×	-0.57×	-96.7%	-262.7%	-9240.7%	-9857.3%	201.9%	786.9%	-119.5%	-0.08×	0.13×	-14.01×	0.54×	11.8%	3	-20.16	1	C-
CRISCuris, Inc.	$0.74	-1.7×	2.38×	1.38×	-1.83×	-1429.1%	99.5%	-348.4%	-80.3%	-138.8%	-464.7%	-209.4%	0.3×	0.66×	-15.06×	0.49×	0.0%	0	-98.45	1	C-
DAREDare Bioscience, Inc.	$0.66	-1.61×	75.9×	209.43×	-18.58×	-72.9%	-137.5%	-1315.5%	-1300.7%	-471.4%	-124.5%	-4.8%	0.93×	2.12×	-16.47×	1.14×	0.0%	2	-13.47	2	C+
Peer median	—	-1.61×	0.93×	56.41×	-1.9×	-536.9%	-137.5%	-1315.5%	-1300.7%	-138.8%	-124.5%	-66.4%	0.3×	0.29×	-16.47×	0.96×	0.0%	2	-20.16	1	—